Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions.
The concentrations of azithromycin in polymorphonuclear leukocytes (PMNLs), monocytes, erythrocytes, and plasma were measured in six healthy volunteers after the last treatment of a 3-day regimen of 500 mg once daily. Marked enrichment of azithromycin was found in PMNLs and monocytes. The drug concentrations after the last dose amounted to 114 +/- 43 (mean +/- standard deviation) mg/liter at 12 h in PMNLs and 34 +/- 17 mg/liter at 6 h in monocytes. Fourteen days thereafter, azithromycin was still detectable in the PMNLs at 53 +/- 34 mg/liter and in the monocytes at 1 +/- 2 mg/liter, although the drug was no longer detectable in plasma (< 0.02 mg/liter). Maximum drug concentrations for azithromycin in plasma (0.40 +/- 0.30 mg/liter) and erythrocytes (0.15 +/- 0.05 mg/liter) at 3 h after the last administration were much lower and occurred earlier than those observed in the phagocytic cells. The mean enrichment factors (cellular/extracellular ratios) of azithromycin in phagocytes relative to plasma came to 231 +/- 150 and 3,924 +/- 584 at 3 and 120 h, respectively, for PMNLs and 83 +/- 55 and 523 +/- 285 at 3 and 120 h for monocytes, respectively, after the last dose. The phagocytosis tests with PMNLs separated from the blood of volunteers at various times after the last treatment confirmed the enhanced intracellular activity of these cells against staphylococci.
Wildfeuer
A
A
Department of Research and Development, Pfizer/Mack, Illertissen, Germany.
Laufen
H
H
Zimmermann
T
T
D000284:Administration, Oral; D000328:Adult; D000900:Anti-Bacterial Agents / Q000097:blood* / Q000493:pharmacokinetics* / Q000494:pharmacology; D017963:Azithromycin / Q000097:blood* / Q000493:pharmacokinetics* / Q000494:pharmacology; D004912:Erythrocytes / Q000378:metabolism / Q000382:microbiology; D006801:Humans; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism / Q000382:microbiology; D008297:Male; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism / Q000382:microbiology; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism / Q000382:microbiology; D010587:Phagocytosis / Q000187:drug effects
D000900:Anti-Bacterial Agents; D017963:Azithromycin